News

Agilent Receives European IVDR Certification for Companion Diagnostic Assay in Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
Agilent Technologies Inc. (NYSE: A) today announced its PD-L1 IHC 22C3 pharmDx (Code SK006) assay has received European IVDR ...
Agilent receives European IVDR certification for IHC 22C3 pharmDx assay
Agilent (A) announced its PD-L1 IHC 22C3 pharmDx assay has received European IVDR certification for the use as a Companion Diagnostic to aid in ...
360Dx3d
Agilent Gains IVDR Certification for Expanded Use of CDx Assay for Keytruda
The PD-L1 IHC 22C3 PharmDx (Code SK006) assay is now certified for use to aid treatment decisions for patients with gastric or gastroesophageal junction adenocarcinoma.
Yahoo Finance28d
Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval
SANTA CLARA, Calif., March 24, 2025--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) is pleased to announce its role in supporting Autolus Therapeutics’ FDA approval for AUCATZYL ®, a ...
Agilent technologies CEO Padraig McDonnell sells $286,650 in stock
Agilent also secured Class C In Vitro Diagnostic Regulation (IVDR) certification for its PD-L1 IHC 28-8 pharmDx, a critical assay used in determining patient eligibility for specific cancer therapies.